Here, comparable to NFS1 amplification in lung cancer, we observed FDX2 gene amplification in a substantial fraction of ovarian cancer (OVC) cases, an observation not previously reported in other cancer types. This evidence concerns the gene FDX2 and ovarian carcinoma.